Lung Cancer, Conjugates Emerge As Key Asia Company Themes
Executive Summary
Among Asia Pacific pharma companies presenting new clinical data on their oncology pipelines at ASCO, lung and urothelial cancer and antibody-drug conjugates emerge as stand-out themes.